GlassScriptPhysician profile
Ross A Wopat
NPI 1477812915
$1,161.96
in general payments reported to CMS, 2019-2025
14 companies · $162 in 2025
The $162 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.30 · 2020: $64.03 · 2021: $92.96 · 2022: $234 · 2023: $63.03 · 2024: $532 · 2025: $162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $757.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $757.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $279.80 | 2021-2025 | Spaceoar Vue System - 10ml |
| Urogen Pharma, INC. | $200.07 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $143.04 | 2024 | Gemtesa |
| Laborie Medical Technologies Corp. | $139.78 | 2020-2024 | Urgent PC Neuromodulation System |
| Tolmar, INC. | $93.88 | 2023-2024 | |
| Coloplast Corp | $75.44 | 2024 | |
| Procept Biorobotics Corporation | $59.30 | 2024-2025 | Aquabeam System |
| Convatec INC. | $46.43 | 2025 | |
| Abbvie INC. | $44.13 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $21.93 | 2025 | Keytruda |
| Accord Healthcare, INC. | $19.50 | 2024 | |
| Pfizer INC. | $13.86 | 2021 | |
| Neotract INC. | $13.30 | 2019 | |
| Myriad Genetic Laboratories, INC. | $11.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ross Wopat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.